GL
IBB icon

Graypoint LLC’s iShares Biotechnology ETF IBB Stock Holding History

Graypoint LLC’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,782
Closed -$228K – 538
2025
Q1 		$228K Buy
1,782
+3
+0.2% +$407 0.01% 470
2024
Q4 		$235K Buy
1,779
+166
+10% +$23.3K 0.01% 464
2024
Q3 		$235K Buy
1,613
+125
+8% +$18.1K 0.02% 453
2024
Q2 		$204K Buy
+1,488
New +$199K 0.01% 459

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Graypoint LLC's IBB Position: Q2 2025 in Review

Graypoint LLC sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 1,782 shares — an estimated $228K sold.

Graypoint LLC first reported a position in IBB in Q2 2024 and held it in 4 quarters. The position peaked at $235K in Q4 2024. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

  • Graypoint LLC reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • Graypoint LLC sold 1,782 iShares Biotechnology ETF shares in Q2 2025, an estimated $228K.
  • Graypoint LLC first reported a position in iShares Biotechnology ETF in Q2 2024 and held it in 4 quarters.
  • Graypoint LLC's iShares Biotechnology ETF position peaked at $235K in Q4 2024.
  • 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.